Purpose: Conventional MRI using contrast agents is semiquantitative because it is inherently sensitive to extravoxular susceptibility artifacts, field inhomogeneity, partial voluming, perivascular effects, and motion/flow artifacts. Herein we demonstrate a quantitative contrast-enhanced MRI technique using ultrashort time-to-echo pulse sequences for measuring clinically relevant concentrations of ferumoxytol, a superparamagnetic iron oxide nanoparticle contrast agent with high sensitivity and precision in vitro and in vivo. Methods: The method achieves robust, reproducible results by using rapid signal acquisition at ultrashort time-to-echo (UTE) to produce positive contrast images with pure T 1 weighting and little T 2 * decay. The spoiled gradient echo equation is used to transform UTE intensities directly into concentration using experimentally determined relaxivity constants and image acquisition parameters. Results: A multiparametric optimization of acquisition parameters revealed an optimal zone capable of producing highfidelity measurements. Clinically relevant intravascular concentrations of ferumoxytol were measured longitudinally in mice with high sensitivity and precision ($7.1% error). MRI measurements were independently validated by elemental iron analysis of sequential blood draws. Automated segmentation of ferumoxytol concentration yielded high quality threedimensional images for visualization of perfusion. Conclusions: This ability to longitudinally quantify blood pool CA concentration is unique to quantitative UTE contrastenhanced (QUTE-CE) MRI and makes QUTE-CE MRI competitive with nuclear imaging. Magn Reson Med 000:000-000, 2014. V C 2014 Wiley Periodicals, Inc.
INTRODUCTION
The ability to measure structural and functional features of health and disease is limited by our current clinical imaging toolbox. Advances in patient monitoring and follow-up need to be quantitative, objective, specific, sensitive, reproducible, and safe (1) (2) (3) . Currently, only nuclear medicine provides an effective means of quantifying contrast agents (CAs) in vivo (4) . However, the radioisotopes involved in these procedures are hazardous, thus the use of nuclear medicine is not warranted for repeat structural and functional imaging (5) . Clinical implementation of alternative quantitative imaging techniques could revolutionize patient care.
MRI provides information about blood and tissue without the use of harmful radiation. Over the last decade, many researchers have attempted to collect and analyze MRI data in a quantifiable manner (6) . MRI, however, remains semiquantitative because it is inherently sensitive to extravoxular susceptibility artifacts, field inhomogeneity, partial voluming, perivascular effects, and motion/ flow artifacts (7) . Imaging techniques that employ a timeto-echo (TE) of half a millisecond or more are particularly susceptible to heterogeneous signal modifications and are therefore difficult to interpret (8) . Despite the relationship between MRI signal intensity and CA concentration being widely recognized to be complex and nonlinear (8, 9) , current models for contrast CA quantification assume a linear relationship between signal intensity and CA concentration or a linear relationship between CA concentration and relaxation rate (10) (11) (12) (13) . The error for these models varies from 15% to 30% (Table 1) , which is attributed to complicated in vivo signal artifacts, such as flow, organ movement, and susceptibility changes. Given the current limitations in absolutely quantitative MRI, new acquisition and analysis methods are greatly needed.
We report a quantitative contrast-enhanced MRI technique that uses an ultrashort time-to-echo (UTE) to generate positive-contrast images of superparamagnetic iron oxide nanoparticles (SPIONs) in vivo. Ultrafast (e.g., 10-200 ms) signal acquisition has the benefit of producing positive contrast images instead of dark contrast images by acquiring signal before tissue magnetization in the transverse plane dephases (14) , thus allowing complete T 1 contrast enhancement from SPIONs (15) . We hypothesize that UTE is uniquely suited for measuring the concentration from clinically relevant concentrations of FDA-approved ferumoxytol. Here, we demonstrate that quantitative UTE contrastenhanced (QUTE-CE) MRI is a robust technique for quantifying blood pool ferumoxytol in vitro error 3.0% and in vivo 7.1% error in the clinical range. The image acquisition method is anchored in theory and is compatible with existing clinical SPION formulations and scanners, thus QUTE-CE MRI shows high potential as a quantitative imaging method that is immediately applicable to human scans.
THEORY
The image intensity in a given voxel measured by QUTE-CE MRI is a function of both image acquisition and material parameters:
where TE is the time-to-echo, TR is the repetition time, and u is the flip angle. TE, TR, and u are image acquisition parameters defined by the user. T 1 and T 2 * are the longitudinal and transverse relaxation times, respectively, that depend on the medium under investigation and the magnetic field strength. K is the constant that relates the UTE signal intensity as seen by the coil and q is the proton density of the medium. For ultrashort TE values, T 2 * effectively equals T 2 .
T 1 and T 2 can be written in terms of their reciprocals, called relaxation rates R 1 and R 2 , respectively, for the facile determination of relaxivity constants. For imaging at a single magnetic field strength (7T in this study), the explicit field dependence is omitted. Here, the medium under investigation is ferumoxytol (Feraheme, AMAG Pharmaceuticals, Waltham, Massachusetts, USA) uniformly mixed in blood. Thus, R 1 and R 2 are a function of the initial relaxation rate of the blood (R 10 and R 20 ), the longitudinal and transverse relaxivities (r 1 and r 2 ), and ferumoxytol at given concentrations C.
For concentrations in which the relaxation rate is linear,
Under these approximations, the UTE signal intensity can be approximated by the spoiled gradient echo (SPGR) equation (16) I¼Kr
I¼Kr Á e ÀTEÁðR2 0 þr2ÁCÞ Á sin u Á 1 À e ÀTRÁðR1 0 þr1ÁCÞ
1 À e ÀTRÁðR1 0 þr1ÁCÞ Á cos u [4] Once the relaxivity constants have been obtained, the image acquisition parameters have been established, and Kq has been calibrated, unknown SPION concentrations can be quantified experimentally using Equation [4] . This procedure was validated both in vitro and in vivo using the techniques described below.
METHODS
QUTE-CE uses CA-induced T 1 shortening, combined with rapid signal acquisition at UTEs, to minimize T 2 * decay. The procedure is summarized in Figure 1 . The relevant steps are as follows:
1. Calibration phantoms containing blood (1% heparin) are doped with clinically relevant concentrations of ferumoxytol (0-150 mg/mL); 2. for each calibration sample, T 1 and T 2 are measured, from which R 10 , r 1 , R 20 , and r 2 can be extrapolated ( Supplementary Fig. 1 ); 3. a UTE protocol is established with optimized TE, TR, and u image acquisition parameters and a fixed is the signal intensity at TE ¼ 0, and C 2 is the signal intensity at TR ¼ 1 ( Supplementary Fig. 1 , Supplementary Table 1 ). Three separate experiments were performed and the relaxivities were averaged to reduce statistical error. In one experiment, 2-mL ferumoxytoldoped blood phantoms were scanned one at a time (mouse blood), whereas in two other experiments, six ferumoxytol doped phantoms filled with calf blood (0-250 mg/mL ferumoxytol) were arranged in pentagonal fashion, with the 0 mg/mL vial at the center. Only measurements from 0-150 mg/mL ferumoxytol were used to calculate relaxivity to remain in the linear relaxation rate regime. For T 1 measurements, the image acquisition parameters were as follows: field of view (FOV) ¼ 5 Â 5 cm 2 ; 2 mm slice thickness, TE ¼ 4.2 ms; TR ¼ 100-2500 ms; rare factor of 1; 17 min, 26 s scan time. No saturation pulse was used, and the maximum TR of 2500 ms was greater than 5 T 1 for all doped blood concentrations. For T 2 measurements, the image acquisition parameters were as follows: FOV ¼ 5 Â 5 cm 2 ; 3 mm slice thickness; TR ¼ 1500 ms; TE ¼ 4.2-133.2 ms (30 echoes); 4 min, 34 s scan time. The large range of TE values was needed to accommodate all concentrations present in the imaging space. Decay and growth curve fits can be found in Supplementary Figures 2, 3 , and 4. For mouse blood, ferumoxytol-doped phantoms were placed inside the coil individually to reduce noise, and TE and TR values were adjusted for each concentration range individually for optimal curve fitting. All relaxivity measurements were made inside a 72-mm Bruker quad coil.
The relaxivity of calf blood was determined to be comparable to that of mouse blood, and all calculations using relaxivity constants were performed using the average fittings from the three separate measurements: R 10 (19) . The r 2 for water was 95 mM À1 Ás À1 , the difference attributed here as either influenced by the media under study (blood versus water) or inaccuracies in the multiecho spin-echo measurements. Nevertheless, T2/ T2* decay for the experiments made herein would be negligible; even at a ferumoxytol concentration as high as 150 mg/mL, an r 2 of 100 mM À1 Ás À1 would only amount to a 0.29% decay of signal from the SPGR equation at TE ¼ 120 ms (the high range for the optimization experiment) or a 0.03% decay at TE ¼ 13 ms (the value used for in vitro and in vivo experiments); consequently, inaccuracies in this measurement played a negligible role in our calculations.
Kq Calibration
Unlike the four relaxivity constants in Equation [4] , which only need to be measured for each magnetic field strength, Kq is a constant that needs to be determined for each imaging protocol, as it depends on acquisition parameters (TE, TR, u, matrix size) and coil hardware. Thereafter, Kq can be used for all subsequent scans. Calibrating Kq is straightforward and was executed using the following steps:
1. Ferumoxytol-doped blood was prepared at known concentrations. 2. A UTE protocol with specific acquisition parameters was performed using the phantoms as prepared from Step 1. 3. ROIs were drawn on the images inside the vials in the center z-axis axial slice of the three-dimensional (3D) image to obtain a mean intensity and standard deviation. 4. The intensity from Step 3 was used in conjunction with the SPGR equation to determine Kq (TE, TR, u, C are known parameters, and relaxivity constants were measured in a previous experiment). 5 . The average value of Kq was taken as a calibration constant.
Once this procedure was completed, Kq was used for all subsequent quantitative calculations using this protocol.
In Vivo Experimental Procedure
All animal experiments were conducted in accordance with the Northeastern University Division of Laboratory Animal Medicine and Institutional Animal Care and Use Committee The same quadrature 300 MHz, 30 mm Mouse MRI coil was used for all in vivo work (Animal Imaging Research, LLC, Holden, Massachusetts, USA). Healthy anesthetized Swiss Webster mice (n ¼ 5) received a one-time intravenous bolus injection of 0.4-0.8 mg ferumoxytol for a starting blood pool concentration of 100-200 mg/mL (diluted to 4 mg/mL in phosphate-buffered saline) and were imaged longitudinally after injection (0, 2, and 4 h). Precontrast images were also acquired. Given the assumption that blood in mice is about 7% of body weight, for a 50-g mouse an initial yield of 115-230 mg/ mL was predicted. This is similar to clinical concentrations where an injection of 510 mg produces a blood concentration of about 100 mg/mL for a total blood volume in the average adult human of 5 L.
A single UTE protocol was used for all images. To establish the UTE protocol, the following parameters were fixed: FOV ¼ 3 Â 3 Â 3 cm 3 ; matrix mesh size ¼ 200 Â 200 Â 200; TE ¼ 13 ms; TR ¼ 4 ms; and u ¼ 20
. TR was slightly higher than the optimal value because of hardware and memory constraints. We analyzed a 50-mL cylindrical phantom filled with 5 mM CuS0 4 to determine the k-trajectories for image reconstruction.
Image Processing
Reconstructed 3D intensity image data were rescaled back to the original intensity measurement (as necessary with Bruker file format files, one must divide by the receiver gain and multiply by scaling factor called SLOPE). Intensity data were then converted to concentration via theory using a custom MATLAB (MathWorks, Natick, Massachusetts, USA) script to solve numerically the nonlinear SPGR intensity in Equation [4] . The signal-to-noise ratio (SNR) is defined as the average signal from an ROI divided by the standard deviation of the noise, as measured in an ROI located in air outside the sample. For the contrast-to-noise ratio (CNR) in phantoms, the mean signal from undoped blood intensity was subtracted from the measurement made in doped blood; for in vivo measurements, tissue surrounding the vasculature was used for contrast. The time-adjusted SNR and CNR take into account the duration of the scan by dividing by ffiffiffiffiffiffi ffi TR p , which normalizes SNR and CNR by the scan time.
Autosegmentation Using 3DSlicer
3D autosegmentation was rendered with 3DSlicer (http:// www.slicer.org) (20) using established modules. First, all voxels within the range of the mean concentration 6 2.5 standard deviations as measured in the left ventricle were selected (ThresholdEffect module). The GrowCut algorithm module was then used to separate out the vasculature from the rest of the image. The ChangeLabel Effect module was used to uniquely select the vasculature segment, for which a model was created with the Model Maker module.
Inductively Coupled Plasma Atomic Emission Spectroscopy
Inductively coupled plasma atomic emission spectroscopy (ICP-AES) was performed to analyze the iron-oxide nanoparticle (IONP) content in doped whole animal blood. Briefly, preparation of IONP-doped media involved the full digestion of the sample in a Milestone Ethos Plus Microwave. Full digestion was achieved by taking 0.1 mL of sample and adding 6 mL of concentrated nitric acid, 2 mL of hydrogen peroxide, and 2 mL of pure water and running a protocol on the microwave that ramped the temperature up to 210 C for 15 minutes. Following digestion, the samples were dried, resuspended in 5 mL of 2% nitric acid, and measured using ICP-AES. A standard curve using a monoelemental iron was run to ensure high instrument fidelity (r 2
RESULTS

3D UTE-CE Imaging with Ferumoxytol
3D UTE-CE imaging with ferumoxytol produced unique images, as most organs that are completely invisible without SPIONs contrast become visible with SPIONs contrast (Fig. 2a,c) . Precontrast signal from blood entering the periphery of the image space into the stomach was apparent because of incoming water protons with fresh longitudinal magnetization compared with those that had already been saturated. Postcontrast images rendered high CNR images of all the vasculature in which nanoparticle iron circulated (Fig. 2b,c) . Thus, UTE allowed for completely T 1 -weighted snapshot images of CA distributed in vivo. This is atypical in MRI, in which contrast is usually added or subtracted from already apparent regions, and more like nuclear imaging techniques, from which image contrast is solely dependent on CA location and concentration.
UTE Experiments Reveal an Optimal Zone at 7T
The ability to predict CA concentrations from UTE intensity using the SPGR equation is influenced by image acquisition parameters TE, TR, and u. A 3D UTE radial k-space sequence (readily available from the Bruker toolbox) was selected, and the following imaging protocol was established: FOV ¼ 3 Â 3 Â 3 cm 3 ; matrix mesh size ¼ 128 Â 128 Â 128; and 51,360 radials, which rendered 234 mm x-y-z resolution images with a 3-min scan time for TR ¼ 3.5 ms. The image reconstruction trajectory was fixed using a 5-mM copper sulfate (CuSO 4 ) phantom constructed from a 50-mL centrifuge tube. Experiments were performed on whole calf and mouse blood (1% heparin) doped with ferumoxytol (0-250 mg/mL). We used a high bandwidth radiofrequency pulse to avoid complications for cases in which a low bandwidth compared with T 2 * may cause a curved trajectory for the magnetization vector M z out of the z-plane (21) . Assuming T 2 * &asymp; T 2 at UTE values, the 200 kHz bandwidth yielded ultrafast excitation compared with the lowest T 2 value of 5.5 ms at 150 mg/mL. All experiments performed on acquisition parameters optimization were performed with a 72-mm Bruker quad coil.
For calf blood, 100 scans were executed covering combinations of five TEs (13, 30, 60, 90, and 120 ms), five TRs (3.5, 5, 7, 9, and 11 ms), and four us (10 , 15 , 20 , and 25 ). Six 2-mL phantoms of ferumoxytol-doped calf blood at (0-250 mg/mL ferumoxytol) were arranged in pentagonal fashion with the 0 mg/mL vial at the center inside of a 72-mm Bruker quad coil. Kq was calibrated per image, with the 0 concentration exceptionally excluded in calculations because the noise from surrounding high concentrations rendered a poor measurement. It was found that higher concentration UTE signals deviated from their optimal values from the SPGR equation, owing to the nonlinear behavior of the relaxation rate at high concentrations, thus only 0, 50, 100 and 150 mg/ml phantoms were considered in the analysis in Figure 3 . The results are thus relevant for clinical concentrations of ferumoxytol, considering 100 mg/mL is roughly equivalent to a single intravenous bolus of 510 mg in adult humans. Accuracy was observed to be most stable at TE ¼ 13 ms, TR ¼ 3.5 ms, and u ¼ 20 (Fig. 3a) . In this optimal zone, the average in vitro error between QUTE-CE measurements and known ferumoxytol concentrations was <4 mg/mL, but increased significantly as TR and u deviated (Fig. 3b) . However, changes in TE up to 120 ms had little impact on concentration measurements (Fig. 3c) . This information is crucial for obtaining precise concentration measurements from theory, and to our knowledge represents the first such account in the literature. The agreement between the measured signal intensity and the SPGR equation for known concentrations at the optimized parameters was excellent (Fig. 3d) . The absolute values for SNR and CNR at 150 mg/mL ferumoxytol in the optimal zone were 72 and 57, respectively (Fig. 3e) . The time-corrected SNR and CNR also tended to be higher in the optimal zone ( Supplementary Fig. 5 ). Relaxation rate measurements were repeated after the experiment to ensure that no blood coagulation was present (Supplementary Fig. 1) . These results validate the use of the SPGR equation (Eq. [4] ) to determine unknown concentrations and are the basis of QUTE-CE MRI.
To ensure validity of phantom measurements, experiments were repeated with mouse blood with five TEs (14, 30, 60, 90, and 120 ms) and five TRs (4, 5, 7, 9, and 11 ms) at u ¼ 20
( Supplementary Fig. 6 ). Six 2-mL vials of ferumoxytol (50, 75, 100, 125, 150, and 175 mg/mL) were arranged around a center vial of 5 mM CuSO 4 .The same pattern for the optimal zone was confirmed in mouse blood, with absolute concentration errors similar to the previous experiment.
QUTE-CE Calibration and Validation for Mouse Imaging
The same imaging protocol and coil was used as for in vivo experiments (see Methods). Phantoms (0-150 mg/mL ferumoxytol) were placed one at a time for calibration of Kq to produce ideal images with low noise (Fig. 4a) . This protocol and calibration was used for all subsequent in vitro and in vivo experiments.
To assess in vitro performance of QUTE-CE MRI, doped phantoms were created by serial dilution of ferumoxytol from 128 and 96 mg/mL. 3D UTE was performed and concentrations were calculated voxel by voxel for images containing multiple phantoms ( Supplementary  Fig. 7) . A linear correlation (R 2 ¼ 0.998) was observed between the measured and known ferumoxytol concentrations (Fig. 4b) . The average residual error in measured concentration was found to be 2.57 6 1.34 mg/mL, or 3.04% for samples between 48 and 128 mg/mL (Fig. 3b,  insert) . Measurements were taken at the center of the zaxis in the imaging space, after converting from UTE intensity to concentration (Fig. 4c,d) , to minimize inhomogeneous effects from imperfect transmit field (B þ 1 ) and receive (B À 1 ) homogeneity. We assessed the effect of B1 inhomogeneity on concentration measurements as a function of distance deviated from the center z-axis along the tubular phantoms as far as possible in the 3D images (Fig. 4e, Supplementary Fig. 8) . B 1 inhomogeneity was most significant for the highest concentrations, adding about 10% error to the 128 mg/mL phantom at a distance of 50 mm.
Quantification of Blood Pool Ferumoxytol In Vivo
Comparison of the precontrast (Fig. 5a ) and postcontrast (Fig. 5b) images showed positive-contrast enhancement, facilitating clear delineation of the mouse vasculature with a comparable SNR (23.2-49.4) and CNR (4.0-41.5) to similar ferumoxytol concentrations in vitro. 3-D segmentation with 3DSlicer, centered the measured mean concentration 6 2.5 standard deviations, allowed reconstruction of numerous vessels (Fig. 5c) . To quantify ferumoxytol concentration in blood, blood (200 mL) was drawn after each imaging session and its iron content was measured by ICP-AES analysis (Fig. 5d, Supplementary Fig. 9 ). QUTE-CE proved to be highly accurate, with an average of 7.07% (6.01 6 4.93 mg/mL) error across all 15 measurements (concentrations 30-160 mg/mL). The maximum observed residual error in vivo was 13.50 mg/ mL, compared to 5.0 mg/mL in vitro (Fig. 5d, inset) . The linear correlation coefficient between ICP-AES and QUTE-CE measurements was R 2 ¼ 0.954. The QUTE-CE ROI for quantification was routinely drawn in left ventricle throughout several slices (Fig. 5d, insert) and analyzed in a blinded manner. Almost all ROIs were within 5 mm of the center of the z-axis, which minimized error from B 1 inhomogeneity; thus there was no correlation between error and distance to the center of the z-axis. Longitudinal measurements of ferumoxytol concentration in vivo showed a clear, reproducible decay in blood pool concentration, making it possible to measure the half-life of the CA from images alone. The ferumoxytol half-life was found to be 3.92 6 0.45 h, with an average R 2 ¼ 0.988 across five mice (Fig. 5e ).
DISCUSSION
Ferumoxytol and other SPIONs are generally considered poor candidates for quantitative imaging due to their high T 2 * relaxivity, which results in negative-contrast imaging (22) . However, the biocompatibility of SPIONs makes them an attractive candidate for nanoparticle contrast-enhanced MRI (23) (24) (25) , and even as an alternative to the widely used gadolinium contrast agents, which is now recognized to result in nephrotoxicity, particularly for renally impaired patients (26, 27) . Quantification of SPIONs using ultrafast acquisition with UTE or SWIFT pulse sequences is currently under investigation (28, 29) . Our use of the UTE pulse sequence, which allows us to acquire a signal before the transverse magnetization is dephased (14) , takes advantage of the r 1 relaxivity of SPIONs. The ferumoxytol concentration is directly extrapolated from measured signal intensity by using the SPGR equation, which describes the signal evolution and holds true under the optimized conditions studied here. Published methods to quantify CA concentration (Table 1) generally rely on the linear relationship between measured signal intensity or R 1 relaxation rate and concentration. There still remains a high degree of error with this approach in vivo, reported on the order of 15%-30% (11-13), due to heterogeneous, nonlinear signal changes that are not adequately described by theory when measuring in vivo. Complex nonlinear modeling has shown limited success (9,30,31) (13% 6 9% error in vivo) but is sensitive to magnetic susceptibility, imperfect B 0 shimming, and chemical shifting, all of which worsen at longer TEs and are thus avoided in QUTE-CE MRI. More recently, researchers have attempted to distinguish between CA and tissue signals using a custombuilt coil to introduce a time-dependent magnetic field; however, no in vivo results have been reported (32) .
Our ability to achieve robust, reproducible results is primarily physical and is contingent on multiparametric optimization of TE, TR, and u. By choosing optimized image acquisition parameters to minimize the error in concentration, including UTE, we were able to use the SPGR equation to accurately measure ferumoxytol concentrations in vitro and in vivo. This optimized UTE protocol allows signals to be acquired microseconds after excitation, before cross-talk between voxels can occur, thereby eliminating both extravoxular susceptibility and flow effects. Indeed, the average blood flow velocity in mice is $10-100 mm/s (excluding the largest arteries) (33) , thus blood displacement is two orders of magnitude less than the voxel size during image acquisition. A low TR suppresses flow effects for concentration quantification as well as suppressing precontrast tissue signal, rendering high SNR and CNR ratios similar to those observed in vitro. Importantly, this optimization of the UTE protocol yields a strong correlation between the theory and experimental measurements, allowing the QUTE-CE image contrast to be quantified with a precision two to four times that of other reported techniques.
Longitudinal QUTE-CE measurements can be used to determine pharmacokinetic parameters. We have demonstrated the ability to distinguish time-dependent changes in blood pool ferumoxytol concentration with a precision of $0.1 mM at 7T up to $3 M for the estimation of CA half-life. These measurements were independently validated ex vivo using ICP-AES. The ferumoxytol half-life measured in mice by QUTE-CE MRI (3.92 6 0.45 h) is comparable to that measured by others using radiolabeled ferumoxytol in rats (3.9 h) and rabbits (4.4 h) (34) . Importantly, QUTE-CE concentration measurements are extrapolated directly from UTE signal intensities, without pharmacokinetic modeling or image registration. As such, no assumptions about tissue structure or function, or heterogeneities contained therein, are required for concentration analyses. This ability to longitudinally quantify blood pool CA concentration is unique to QUTE-CE MRI.
Transitioning QUTE-CE MRI for clinical use will require overcoming several additional challenges. Utilization on clinical machines may result in larger B 0 and B 1 inhomogeneity. The placement of the coil can vary between patients on a clinical machine, which can lead to additional error resulting from the varying B 0 profile. Standardization of patient placement may be effective in reducing this error. B 1 inhomogeneity may be greater in larger coils, thus the extent to which B 1 inhomogeneity is present should be determined for x, y and z locations within the coil. We have shown that measurements taken at the coil center in vitro minimized this effect. A future improvement of the technique could include rapid B þ 1 mapping to correct for inhomogeneity (35) or use of a homogeneous phantom to accompany patients for backcalculating the flip angle along the z-axis.
These challenges may be offset by increases in sensitivity and a decreased scan time. The ferumoxytol operating range and precision should decrease as a function of magnetic field strength. For example, transitioning from a research grade (7T) to clinical grade (1.5T or 3T) scanner would lower the measurable concentration range by a couple of orders of magnitude due to increased CA r 1 relaxivity at lower field strengths (36) , although organs may no longer be as invisible to UTE pulse sequences compared with 7T. The use of clinically available multichannel coils is expected to increase SNR and accelerate scan time.
Ferumoxytol-based blood-pool functional diagnostics may be the most immediate application of QUTE-CE MRI. Current functional MRI techniques, such as dynamic contrast-enhanced MRI, are unable to produce robust, reproducible results due to their inability to measure the intravascular CA concentration as a function of time (37, 38) . A 3D QUTE-CE image could be employed after a sequence of short two-dimensional (2D) images to provide a time point to better fit the model for the arterial input function. Alternatively, 2D QUTE-CE MRI could be used for more rapid scanning, provided sufficiently rapid gradient ramp-up time. However, imaging with a 2D sequence or 3D slice-select sequence would not benefit from the reduction in flow effects, which proved important for quantitative imaging by providing adequate homogeneity in flip angle excitation (i.e., whole sample excitation at low TR). Thus, we would recommend using a saturation prepulse before application of the slab or slice select pulse. Nevertheless, the effectiveness of 2D quantitative imaging with QUTE-CE is yet to be determined.
Quantification of CA accumulation in tissues is also of great clinical interest (39) . It would be interesting to explore whether QUTE-CE MRI is compatible with other CAs, including various blood pool agents, organ-specific agents, and tumor-specific agents (28, 40) . CAs that produce significant T 1 shortening are likely to provide even higher contrast and precision than ferumoxytol. However, obtaining measurements outside of vasculature introduces additional complexities due to differences in CA relaxivity between blood, extracellular space, and intracellular compartments (41) and is the subject of future studies. It may also require an accurate R 10 map before contrast administration. However, because any concentration measurement with MRI would have to overcome these additional complexities in tissue, we expect signal measurements from this method to maintain its advantages concerning the time-dependent process of signal perturbation that occurs at longer TEs. Wherever QUTE-CE MRI may prove successful, autosegmentation under user-specified conditions would provide unbiased, efficient delineation of features of interest (42) .
CONCLUSIONS
The method described here allows clinically relevant concentrations of ferumoxytol to be measured noninvasively and quantitatively with high precision. We demonstrate that QUTE-CE MRI data show excellent agreement with theory when image acquisition parameters are preoptimized to reduce error. The robustness of this technique is based on the use of UTE, which allows the SPGR equation to be applied. Longitudinal measurements of blood pool ferumoxytol can be acquired in vivo with high precision for estimation of ferumoxytol halflife. This ability to longitudinally quantify blood pool CA concentration is unique to the QUTE-CE method and makes MRI competitive with nuclear imaging. We see immediate potential for diagnostic functional imaging with ferumoxytol. Future preclinical adaptions may include measurements of other CAs in organs outside the vasculature for image-guided drug delivery.
